Metabolomics Market Size to Reach USD 6,663 Million by 2030 at a CAGR of 12.2% | Valuates Reports

BANGALORE, India, April 5, 2022 The Global Metabolomics Market is Segmented by Product and Service (Metabolomics Instruments and Metabolomics Bioinformatics Tools & Service), Application (Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics, Personalized Medicine, and Others), and Indication (Cancer, Cardiovascular Disorders, Neurological Disorders, Inborn Errors of Metabolism, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030.

The Global Metabolomics Market size was valued at USD 2,032 Million in 2020 and is projected to reach USD 6,663 Million by 2030, registering a CAGR of 12.2% from 2021 to 2030.

Major factors driving the growth of the metabolomics market are:

Increased adoption of metabolomics in precision medicine and the introduction of diagnostic tests for chronic disease diagnosis are driving the global metabolomics market. Furthermore, market growth is expected to be boosted by technological advancements in analytical techniques and an increase in R&D spending.

The recent COVID-19 outbreak, as well as the need for biomarker development and early disease diagnosis, are expected to propel the Metabolomics market forward.

Get Your Sample Today: https://reports.valuates.com/request/sample/ALLI-Auto-0P183/Metabolomics_Market 

TRENDS INFLUENCING THE GLOBAL METABOLOMICS MARKET

One of the key factors driving the growth of the global metabolomics market is the growing acceptance of metabolomics in personalized medicine. Through the development of personalized phenotyping and individualized drug-response monitoring, metabolomics is beginning to play a role in precision medicine. The most 'avant-garde' example of metabolomics enabling precision medicine is the use of metabolomics to phenotype tumors and design custom cancer therapies.

Additionally, the rising prevalence of chronic degenerative diseases such as cancer, cardiovascular disease, and neurological disorders is expected to provide lucrative growth opportunities for the global metabolomics market. Because cancer is known to alter cellular metabolism, metabolomics can aid in the early detection and diagnosis of cancer, as well as the evaluation of medical interventions and cancer therapies. Recent advances in analytical technologies and statistical capabilities have enabled metabolomics to delve deeper into cancer metabolism and provide insight into how cancer cells use glycolysis to produce amino acids, nucleotides, and lipids required for tumor proliferation and vascularization.

The metabolomic market has a lot of potential in disease diagnosis. Early detection of chronic diseases allows healthcare providers to plan for effective disease treatment, increasing patient survival rates and assisting in the disease's complete elimination from the patient's biological system.

The impact of COVID-19 on the metabolomics market has been positive. This is because metabolomics is used in research to better understand diseases, according to COVID-19. Changes in the plasma metabolome, for example, reflect COVID-19 patients' clinical presentation in mild, moderate, and critical COVID-19 cases. At least 77 metabolites, including amino acids, lipids, polyamines, and sugars, as well as their derivatives, were altered in critical COVID-19 patient's plasma compared to mild COVID-19 patients. As a result, there has been an increase in the use of metabolomics in COVID-19-related research, which has had a positive impact on the metabolomics market.

Through bioinformatics tools, metabolomics is used to identify new biomarkers, which indicate changes in the physiological state of a cell or tissue. In-vitro diagnostic tools, environmental toxicology screening methods, and drug discovery and development techniques all rely on biomarkers. In medical science, biomarkers are needed to better define and diagnose diseases, predict adverse drug events, and identify patient groups who would benefit from specific treatments. Furthermore, identifying biomarkers related to drug safety, sensitivity, and resistance will present significant growth opportunities for the metabolomics market in the near future.

Browse The Table Of Contents And List Of Figures At: https://reports.valuates.com/reports/ALLI-Auto-0P183/metabolomics 

METABOLOMICS MARKET SHARE ANALYSIS

Based on product and service Metabolomics Bioinformatics Tools & Service segment is expected to be the most lucrative segment. It is expected to grow at the highest CAGR

during the forecast period due to a large number of users of metabolomics analysis tools and services and increasing demand for data management.

Based on application, the personalized medicine segment is expected to be the most lucrative segment during the forecast period.

Based on indication, Cancer is expected to be the most lucrative segment. The oncology sector is heavily investing in metabolomics, which is expected to drive the cancer segment, with the neurological disorder market growing at the fastest rate during the forecast period.

North America is the most profitable region, thanks to high product commercialization rates and sophisticated healthcare research and development initiatives, which are just a few of the factors contributing to its large market share.

Inquire for Regional Data: https://reports.valuates.com/request/regional/ALLI-Auto-0P183/Metabolomics_Market

Key Companies:

• Agilent Technologies INC.,
• BiocratesLife Science AG,
• Bio-Rad Laboratories INC.,
• Bruker corporation,
• Danaher Corporation,
• Human Metabolome Technologies INC.,
• LECO Corporation,
• Metabolon INC.,
• Shimadzu Corporation,
• Water Corporation.

Inquire for Chapter Cost: https://reports.valuates.com/request/chaptercost/ALLI-Auto-0P183/Metabolomics_Market

Buy Now for Single User + Covid-19 Impact :  https://reports.valuates.com/api/directpaytoken?rcode=ALLI-Auto-0P183&lic=single-user

SUBSCRIPTION

We have introduced a tailor-made subscription for our customers. Please leave a note in the Comment Section to know about our subscription plans.

SIMILAR REPORTS:

-  Due to the COVID-19 pandemic, the global Organ-on-a-Chip market size is estimated to be worth USD 80 Million in 2022 and is forecast to a readjusted size of USD 581.2 Million by 2028 with a CAGR of 39.1% during the review period.

-  The global cell therapy market accounted for USD 7,754.89 Million in 2019, and is expected to reach USD 48,115.40 Million by 2027, registering a CAGR of 25.6% from 2020 to 2027.

-  The Global Bioinformatics Market Size is USD 8,614.29 Million in 2019, and is projected to reach USD 24,731.61 Million by 2027, growing at a CAGR of 13.4% from 2020 to 2027.

-  The global Single-Cell Analysis market was valued at USD 3165.2 Million in 2022 and is projected to reach USD 7656.8 million by 2028, registering a CAGR of 13.2% from 2022 to 2028.

-  The global cell culture market accounted for USD 16,107.7 Million in 2019 and is expected to reach USD 36,926.8 Million by 2027, registering a CAGR of 10.9% from 2020 to 2027.

-  The global Genomics market size is projected to reach USD 31240 Million by 2027, from USD 15120 Million in 2020, at a CAGR of 10.8% during 2021-2027.

-  The global Bioinformatics Services market size is projected to reach USD 2967.1 Million by 2027, from USD 1468.2 Million in 2020, at a CAGR of 10.1% during 2021-2027.

-  The global Pharmacogenomics (PGx) market size is projected to reach USD 14590 Million by 2028, from USD 7757.9 Million in 2021, at a CAGR of 9.3% during 2022-2028.

-  The Live Cell Imaging Market is anticipated to grow at the rate of 8.9% CAGR by 2027.

-  Global Metabolomics Reagents Market Insights and Forecast to 2028

Click here to see related reports on Metabolomics Market

ABOUT US:

Valuates offers in-depth market insights into various industries. Our extensive report repository is constantly updated to meet your changing industry analysis needs.

Our team of market analysts can help you select the best report covering your industry. We understand your niche region-specific requirements and that's why we offer customization of reports. With our customization in place, you can request for any particular information from a report that meets your market analysis needs.

To achieve a consistent view of the market, data is gathered from various primary and secondary sources, at each step, data triangulation methodologies are applied to reduce deviance and find a consistent view of the market. Each sample we share contains a detailed research methodology employed to generate the report. Please also reach our sales team to get the complete list of our data sources.

CONTACT US:

Valuates Reports 
sales@valuates.com  
For U.S. Toll-Free Call 1-(315)-215-3225
For IST Call +91-8040957137
WhatsApp: +91-9945648335
Website: https://reports.valuates.com  
Twitter - https://twitter.com/valuatesreports   
LinkedIn - https://in.linkedin.com/company/valuatesreports  

Logo: https://mma.prnewswire.com/media/1082232/Valuates_Reports_Logo.jpg